Dulac Edward J Iii - Net Worth and Insider Trading

Dulac Edward J Iii Net Worth

The estimated net worth of Dulac Edward J Iii is at least $329,445 dollars as of 2024-11-29. Dulac Edward J Iii is the CFO of Fate Therapeutics Inc and owns about 103,926 shares of Fate Therapeutics Inc (FATE) stock worth over $329,445. Details can be seen in Dulac Edward J Iii's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dulac Edward J Iii has not made any transactions after 2024-01-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Dulac Edward J Iii

To

Dulac Edward J Iii Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dulac Edward J Iii owns 1 companies in total, including Fate Therapeutics Inc (FATE) .

Click here to see the complete history of Dulac Edward J Iii’s form 4 insider trades.

Insider Ownership Summary of Dulac Edward J Iii

Ticker Comapny Transaction Date Type of Owner
FATE Fate Therapeutics Inc 2024-01-29 Chief Financial Officer

Dulac Edward J Iii Latest Holdings Summary

Dulac Edward J Iii currently owns a total of 1 stock. Dulac Edward J Iii owns 103,926 shares of Fate Therapeutics Inc (FATE) as of January 29, 2024, with a value of $329,445.

Latest Holdings of Dulac Edward J Iii

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FATE Fate Therapeutics Inc 2024-01-29 103,926 3.17 329,445

Holding Weightings of Dulac Edward J Iii


Dulac Edward J Iii Form 4 Trading Tracker

According to the SEC Form 4 filings, Dulac Edward J Iii has made a total of 10 transactions in Fate Therapeutics Inc (FATE) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Fate Therapeutics Inc is the sale of 1,849 shares on January 29, 2024, which brought Dulac Edward J Iii around $9,245.

Insider Trading History of Dulac Edward J Iii

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dulac Edward J Iii Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Dulac Edward J Iii Ownership Network

Ownership Network List of Dulac Edward J Iii

No Data

Ownership Network Relation of Dulac Edward J Iii

Insider Network Chart

Dulac Edward J Iii Owned Company Details

What does Fate Therapeutics Inc do?

Who are the key executives at Fate Therapeutics Inc?

Dulac Edward J Iii is the Chief Financial Officer of Fate Therapeutics Inc. Other key executives at Fate Therapeutics Inc include director & President and CEO J Scott Wolchko , Chief Development Officer Bahram Valamehr , and See Remarks Cindy Tahl .

Fate Therapeutics Inc (FATE) Insider Trades Summary

Over the past 18 months, Dulac Edward J Iii made 4 insider transaction in Fate Therapeutics Inc (FATE) with a net sale of 18,777. Other recent insider transactions involving Fate Therapeutics Inc (FATE) include a net sale of 4,725 shares made by Yuan Xu , a net sale of 35,237 shares made by Cindy Tahl , and a net purchase of 44,630 shares made by Redmile Group, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Fate Therapeutics Inc (FATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 88,255 shares of Fate Therapeutics Inc (FATE) were sold and 44,630 shares were bought by its insiders, resulting in a net sale of 43,625 shares.

Fate Therapeutics Inc (FATE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Fate Therapeutics Inc Insider Transactions

No Available Data

Dulac Edward J Iii Mailing Address

Above is the net worth, insider trading, and ownership report for Dulac Edward J Iii. You might contact Dulac Edward J Iii via mailing address: Fate Therapeutics, Inc., 3535 General Atomics Court Ste 200, San Diego Ca 92121.

Discussions on Dulac Edward J Iii

No discussions yet.